1 – 10 of 55
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- FRMD6 has tumor suppressor functions in prostate cancer
- 2019
- The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor
- Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality
- 2016
-
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
Lindblad, O LU ; Cordero, E LU ; Puissant, A ; Macaulay, L. ; Ramos, A ; Kabir, N N ; Sun, J LU ; Vallon-Christersson, J LU
; Haraldsson, K
LU
and Hemann, M T
, et al.
(2016)
In Oncogene
35(39).
p.5119-5131
Mark
-
Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer
Englund, E LU ; Bartoschek, M LU ; Reitsma, B LU ; Jacobsson, L LU ; Escudero-Esparza, A LU ; Orimo, Akira ; Leandersson, K LU ; Hagerling, C LU ; Aspberg, A LU
and Storm, P
LU
, et al.
(2016)
In Oncogene
35(43).
p.5585-5596
Mark
- 2015
- Targeting of nucleotide-binding proteins by HAMLET-a conserved tumor cell death mechanism.
-
The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V.
Agarwal, Shruti LU ; Kazi, Julhash U. LU
; Mohlin, Sofie
LU
; Påhlman, Sven
LU
and Rönnstrand, Lars
LU
(2015)
In Oncogene
34(35).
p.4581-4590
Mark
-
TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
Busch, S ; Acar, A ; Magnusson, Y ; Gregersson, P ; Rydén, Lisa LU
and Landberg, G
(2015)
In Oncogene
34(1).
p.27-38
Mark
- Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.
- 2014
-
The PI3-kinase isoform p110δ is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner.
Sun, Jianmin LU ; Mohlin, Sofie LU
; Lundby, A
; Kazi, Julhash U.
LU
; Hellman, U
; Påhlman, Sven
LU
; Olsen, J V
and Rönnstrand, Lars
LU
(2014)
In Oncogene
33(46).
p.5360-5369
Mark